Thursday, 6 December 2012

Trimel testosterone drug meets late stage study goal

(Reuters) - Trimel Pharmaceuticals Corp said its experimental drug to treat hypogonadism, or low testosterone levels, in men met the main goal of a late-stage study.




via Reuters: Health News Read More Here..


Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2012/12/trimel-testosterone-drug-meets-late.html

No comments:

Post a Comment